Cart
sales@molnova.com
Adropin (34-76) (human, mouse, rat)
CAS No. 1802086-30-1
Adropin (34-76) (human, mouse, rat)( —— )
Catalog No. M36656 CAS No. 1802086-30-1
Adropin (34-76) (human, mouse, rat) is a peptide that attenuates liver fibrosis and insulin resistance independent of obesity or food intake.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 312 | In Stock |
|
| 10MG | 471 | In Stock |
|
| 25MG | 753 | In Stock |
|
| 50MG | 925 | In Stock |
|
| 100MG | 1144 | In Stock |
|
| 200MG | 1535 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAdropin (34-76) (human, mouse, rat)
-
NoteResearch use only, not for human use.
-
Brief DescriptionAdropin (34-76) (human, mouse, rat) is a peptide that attenuates liver fibrosis and insulin resistance independent of obesity or food intake.
-
DescriptionAdropin (34-76) (human, mouse, rat) regulates fuel selection preferences in skeletal muscle. Adropin increases insulin-induced Akt phosphorylation and cell-surface expression of GLUT4, in diet-induced obesity (DIO) mouse.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1802086-30-1
-
Formula Weight4499.82
-
Molecular FormulaC190H293N55O68S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (22.22 mM; Ultrasonic )
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
PLpro inhibitor
PLpro inhibitor is a potent papain-like protease (PLpro) inhibitor(IC50 of 2.6 uM).
-
Edetic acid
Edetic acid is a chelating agent commonly used in protein purification, both to eliminate contaminating divalent cations and to inhibit protease activity.
-
PACAP-27 (6-27) (hum...
PACAP (6-27) (human, ovine, rat) is a PACAP receptor antagonist that blocks the canine adrenal catecholamine response to exogenous vasoactive intestinal peptide (VIP). PACAP (6-27) (human, ovine, rat) has the potential to study cardiovascular and neurological diseases.
